发明名称 |
CRYSTALLINE FORMS OF 3-[5-CHLORO-4-[(2,4-DIFLUOROBENZYL) OXY]-6-OXOPYRIMIDIN-1(6H)-YL]-N-(2-HYDROXYETHYL)-4-METHYLBENZAMIDE |
摘要 |
<p>Crystalline forms of the p38 kinase inhibitor 3-[5-chloro-4-[(2,4difluorobenzyl) oxy]-6-oxopyrimidin-1(6H)-yl]-N-(2-hydroxyethyl)-4-methylbenzamide is provided. Also provided are combinations and pharmaceutical compositions comprising the crystalline forms and methods for the prophylaxis and/or treatment of a p38 kinase-mediated condition comprising administering to a subject a therapeutically effective amount of the crystalline forms.</p> |
申请公布号 |
WO2006040649(A1) |
申请公布日期 |
2006.04.20 |
申请号 |
WO2005IB03030 |
申请日期 |
2005.10.03 |
申请人 |
PHARMACIA & UPJOHN COMPANY LLC;SELBO, JON, G. |
发明人 |
SELBO, JON, G. |
分类号 |
C07D239/52;A61K31/513 |
主分类号 |
C07D239/52 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|